FDA Approved: VYTORIN — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) by Organon LLC, updating its labeling and indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heterozygous Familial Hypercholesterolemia
• Homozygous Familial Hypercholesterolemia
• Hyperlipidemia
• Mixed Dyslipidemia

Drugs mentioned

• Vytorin (ezetimibe/simvastatin)

Snippet

SUPPL AP for VYTORIN (EZETIMIBE AND SIMVASTATIN)